Digital Edition: Vol. 2, No. 3 - March 2020 - Market Pathways

article image
ARTICLE SUMMARY:

Inside this issue, the many ways COVID-19 is already impacting medtech: a proposed delay in EU MDR implementation, a reassessment of diagnostics regulations, changed approaches for regulatory submissions and clinical research. We cover these stories and more in the March issue of Market Pathways.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: